Skip to content

Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys

Dan Barouch presenting at CROI 2018. Photo by Liz Highleyman.

PrEP does not raise lipids or alter body fat, safety study finds

Zambia: HIV deaths on treatment underestimated

Darunavir/ritonavir most durable boosted protease inhibitor in European patients, especially those switching treatment for any reason

Communication skills training for healthcare workers improves HIV treatment adherence

US regulators approve new HIV combo pill containing bictegravir

Generic drugs for HIV treatment may save money, but barriers to prescription make savings elusive

Viral suppression protects against long-term liver damage caused by older HIV drugs

Women with HIV less likely to receive recommended treatments for gynaecologic cancers